chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Lymphadenopathy
Clinical narrative: Uneasy stomach; Joint pain; Swollen (left) lymph node; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 13Apr2021 at 16:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications included minerals nos, vitamins nos (CENTRUM), taken for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 23Mar2021 at 16:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 10:00, the patient experienced uneasy stomach, joint pain and swollen (left) lymph node. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events uneasy stomach, joint pain and swollen (left) lymph node were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Erythema, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Rash on  both arms, face and ears; Redness on  both arms, face and ears; Pins and needles on the fingers; Pins and needles on the fingers which turned into numbness; Pain on the right side which radiated down exclusively to the liver.; Pain on the right side which radiated down exclusively to the liver.; This is a spontaneous report from a contactable pharmacist. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via intramuscular route of administration in the left arm on 24Mar2021 at 14:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 14:45 immediately after the vaccine, the patient started experiencing rash and redness on both arms, face and ears. Then patient experienced pins and needles on the fingers which turned into numbness within a couple of minutes. Then 5 to 10 minutes after, the patient started experiencing pain on the right side which radiated down exclusively to the liver. This pain lasted for several days. The patient took a TYLENOL as per the doctor's instruction which did help but the pain came back after the medication wore off. Even at the time of this report, the patient still experienced soreness on the right side where the liver was present. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with TYLENOL and BENADRYL. The clinical outcome of the events rash and redness on both arms, face and ears, pins/needles on the fingers which turned into numbness were recovered with lasting effects on an unspecified date in 2021 while the outcome of pain on the right side which radiated down exclusively to the liver was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on  both arms, face and ears; Redness on  both arms, face and ears; Pins and needles on the fingers; Pins and needles on the fingers which turned into numbness; Pain on the right side which radiated down exclusively to the liver.; Pain on the right side which radiated down exclusively to the liver.; This is a spontaneous report from a contactable pharmacist. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via intramuscular route of administration in the left arm on 24Mar2021 at 14:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021 at 14:45 immediately after the vaccine, the patient started experiencing rash and redness on both arms, face and ears. Then patient experienced pins and needles on the fingers which turned into numbness within a couple of minutes. Then 5 to 10 minutes after, the patient started experiencing pain on the right side which radiated down exclusively to the liver. This pain lasted for several days. The patient took a TYLENOL as per the doctor's instruction which did help but the pain came back after the medication wore off. Even at the time of this report, the patient still experienced soreness on the right side where the liver was present. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with TYLENOL and BENADRYL. The clinical outcome of the events rash and redness on both arms, face and ears, pins/needles on the fingers which turned into numbness were recovered with lasting effects on an unspecified date in 2021 while the outcome of pain on the right side which radiated down exclusively to the liver was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Body temperature, Body temperature abnormal, Chills, Disorientation
Clinical narrative: Swollen underarm; severe pain in underarm; disoriented; temperature for over 24 hours; chills; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 13:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported.  The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 09:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 02:15, the patient experienced swollen underarm, severe pain in underarm, disoriented, temperature for over 24 hours, chills and fatigue. On 14Apr2021, the patient underwent Body temperature and the result was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events swollen underarm, severe pain in underarm, disoriented, temperature for over 24 hours, chills and fatigue was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Swelling
Clinical narrative: Swollen underarm; severe pain in underarm; disoriented; temperature for over 24 hours; chills; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 13:30 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported.  The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 09:00 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 02:15, the patient experienced swollen underarm, severe pain in underarm, disoriented, temperature for over 24 hours, chills and fatigue. On 14Apr2021, the patient underwent Body temperature and the result was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events swollen underarm, severe pain in underarm, disoriented, temperature for over 24 hours, chills and fatigue was not resolved.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Tension headache
Clinical narrative: Severe headache/Migraine; Feels like tension inside the head; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EWO150) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included prenatal vitamins (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Apr2021 at 07:00, 7 days after the shot, the patient experienced severe headache/migraine that lasted for 2 days straight. The patient felt better on 14Apr2021 but still had mild discomfort which felt like tension inside the head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events severe headache/migraine and feels like tension inside the head which included treatment with pain medication but that did not help. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of severe headache/migraine, feels like tension inside the head were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epistaxis, Fatigue, Myalgia, Pain in extremity
Clinical narrative: I also developed a soreness in my left hand, starting with Sunday, April 11. This developed into severe pain even while resting the hand,; Soreness of the upper arm; Sore muscles; Tiredness; I started having nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to some medications. Concomitant medications included salmon oil (MANUFACTURER UNKNOWN), curcumin (CURCUMIN), oenothera biennis oil (EVENING PRIMROSE OIL) and vaccinium macrocarpon (CRANBERRY) for unknown indications taken on unknown dates and unknown if still ongoing. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 18Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021, on the day after the vaccine, the patient experienced expected soreness of the upper arm, sore muscles, tiredness, and had five nosebleeds as of 15Apr2021. On 11Apr2021 at 11:00, the patient experienced soreness in her left hand, pain moving up the arm as far as the shoulder. The events resulted in a visit to emergency room/department or urgent care where the doctor ruled out severe things (blood clots). Unspecified therapeutic measures were taken as a result of all events. The clinical outcome of the event nose bleeds, sore upper arm, sore muscles, tiredness and soreness in her left hand was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Epistaxis, Fatigue, Headache, Injection site pain
Clinical narrative: I also developed a soreness in my left hand, starting with Sunday, April 11. This developed into severe pain even while resting the hand,; Soreness of the upper arm; Sore muscles; Tiredness; I started having nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to some medications. Concomitant medications included salmon oil (MANUFACTURER UNKNOWN), curcumin (CURCUMIN), oenothera biennis oil (EVENING PRIMROSE OIL) and vaccinium macrocarpon (CRANBERRY) for unknown indications taken on unknown dates and unknown if still ongoing. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 18Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021, on the day after the vaccine, the patient experienced expected soreness of the upper arm, sore muscles, tiredness, and had five nosebleeds as of 15Apr2021. On 11Apr2021 at 11:00, the patient experienced soreness in her left hand, pain moving up the arm as far as the shoulder. The events resulted in a visit to emergency room/department or urgent care where the doctor ruled out severe things (blood clots). Unspecified therapeutic measures were taken as a result of all events. The clinical outcome of the event nose bleeds, sore upper arm, sore muscles, tiredness and soreness in her left hand was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Neuropathy peripheral, Pain, Pain in extremity, Tenderness
Clinical narrative: I also developed a soreness in my left hand, starting with Sunday, April 11. This developed into severe pain even while resting the hand,; Soreness of the upper arm; Sore muscles; Tiredness; I started having nose bleeds; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to some medications. Concomitant medications included salmon oil (MANUFACTURER UNKNOWN), curcumin (CURCUMIN), oenothera biennis oil (EVENING PRIMROSE OIL) and vaccinium macrocarpon (CRANBERRY) for unknown indications taken on unknown dates and unknown if still ongoing. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 18Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021, on the day after the vaccine, the patient experienced expected soreness of the upper arm, sore muscles, tiredness, and had five nosebleeds as of 15Apr2021. On 11Apr2021 at 11:00, the patient experienced soreness in her left hand, pain moving up the arm as far as the shoulder. The events resulted in a visit to emergency room/department or urgent care where the doctor ruled out severe things (blood clots). Unspecified therapeutic measures were taken as a result of all events. The clinical outcome of the event nose bleeds, sore upper arm, sore muscles, tiredness and soreness in her left hand was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphoedema, Neck pain, Pain in extremity, Pharyngeal swelling
Clinical narrative: Throat swelling; Lymphedema; Pain to the shoulder; Pain to the neck; Pain to the left arm; This is a spontaneous report from a contactable nurse, the patient A 38-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on 10Apr2021 at 09:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, attention deficit hyperactivity disorder (ADHD), obesity, joint pain, trigeminal neuralgia, eczema, shellfish allergy and allergy to sting. Concomitant medications included sulindac (MANUFACTURER UNKNOWN), amlodipine besilate (NORVASC) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) since unknown dates for unspecified indications. Allergies to medications, food, or other products were reported as shellfish and bee sting. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 10Apr2021 at 09:30, the patient experienced throat swelling, lymphedema, pain to the left arm, pain to the shoulder and pain to the neck. No therapeutic measures were reported as a result of the reported events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of events throat swelling, lymphedema, pain to the left arm, pain to the shoulder and pain to the neck was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lip pain, Lip swelling, Migraine with aura
Clinical narrative: bottom lip is still sore; slightly swollen lip; began experiencing swelling at the site of my lip filler injections in my bottom lip.; got an aura and a migraine; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 11:15(at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, lip filler injection and suffered from migraine. Concomitant medications included birth control (unspecified), escitalopram oxalate (LEXAPRO) and buspirone (MANUFACTURER UNKNOWN) from unknown dates and for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER2613) via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 14Apr2021 at 21:00, the patient experienced swelling at the site of the lip filler injections in the bottom lip. On 14Apr2021, the patient also experienced an aura and a migraine. On 15Apr2021, the patient experienced bottom lip still sore and slightly swollen. The patient took treatment for the events swelling at the site of the lip filler injections in the bottom lip, an aura and a migraine, bottom lip still sore and slightly swollen which included treatment with Benadryl. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events swelling at the site of the lip filler injections in the bottom lip and aura and a migraine was recovering, while that of bottom lip still sore and slightly swollen was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Herpes zoster
Clinical narrative: Had a shingles outbreak about a week ago.; And having big escalation equlibrium issues since about a week post 2nd dose.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and well controlled seizures. The patient had iodine contrast media (reported as iodine based contrast) allergy and contrast media (reported as computed tomography scan contrast dye) allergy. The patient previously took intravenous lidocaine (MANUFACTURER UNKNOWN) for unknown indication and experienced drug allergy in the form of severe bad central nervous system reaction. Concomitant medications taken within two weeks of vaccination included lamotrigine (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL), both from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 22Feb2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient had a shingles outbreak about a week ago before the time of report. The patient was having big escalation equlibrium issues since about a week post second dose on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shingles outbreak about a week ago, having big escalation equlibrium issues since about a week post second dose was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm; very tired; This is a spontaneous report from a non-contactable consumer. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration on 14Apr2021 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration on 24Mar2021 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The information about patient's known allergies to medications, food or other products was not applicable. On 14Apr2021, the patient experienced sore arm and 5 hours after dose patient was very tired, which continued into next day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event sore arm and very tired, which continued into next day was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis
Clinical narrative: Facial Dermatitis; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to strawberries and mangoes. Concomitant medications included estrogens conjugated (PREMARIN), metoprolol (MANUFACTURER UNKNOWN) and amlodipine besilate (MANUFACTURER UNKNOWN); all on unknown date for unspecified indication. Patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 15Mar2021 at 10:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021, the patient experienced facial dermatitis. Therapeutic measures were taken as a result of reported event and included treatment with prednisone, mupirocin and triamcinolone. The event resulted in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event facial dermatitis was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles 3 weeks post second vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 at 08:00 hours (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies (unknown) and drug allergy to (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Feb2021 at 08:00 hours (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient developed shingles 3 weeks post second vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of shingles and included treatment with pain management.  The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: very mild pain, as if poked hard in the arm; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and vertigo. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, on the first day of vaccination, the patient did not feel the injection and had no side-effects. On an unknown date in 2021, day 2 (within 24 hours) of vaccination, the patient experienced very mild pain, as if poked hard in the arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event very mild pain in the arm was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus (continuous, stronger in left ear than right, more of a hum than a ringing); This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the right arm on 28Mar2021 at 08:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HPB), asthma, hemochromatosis, arthritis, and overweight all from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN) all were the medication taken within two weeks of the vaccination for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 07Mar2021 at 08:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Allergy to any medications, food, or other products were reported as none.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 03Apr2021 the patient experienced tinnitus which was continuous, stronger in the left ear than the right, and more of a hum than a ringing. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tinnitus which was continuous, stronger in the left ear than the right, and more of a hum than a ringing, was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: Blood glucose has registered at increased levels and has become less manageable; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6203) via an unspecified route of administration in the left arm on 02Mar2021 at 10:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included type II diabetes mellitus, hypertension and cholesterol. The patient had no known allergies to medications, food or other products. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EM 9810) via an unspecified route of administration in the left arm on 08Feb2021 at 13:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Mar2021 at 11:00 from the time of the vaccination until present, the patient blood glucose had registered at increased levels and had become less manageable. It was reported that there had been major increased levels after rest/fasting during the night. The patient had been monitoring everything closely and in the past 30 days have an average of blood glucose was 203, the highest fasting reading blood glucose was 353. The patient blood glucose lowest and former more normal reading was 107. It was stated that the patient was taking all this data to next doctor visit on 15Apr to assess the situation. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. On an unknown date, the patient underwent blood glucose and the result was 203, 353 and 107 (Unspecified units). The clinical outcome of the event blood glucose had registered at increased levels was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Moderate to severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar 2. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 11:00, the patient experienced moderate to severe fatigue. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event moderate to severe fatigue was resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain
Clinical narrative: lump in left armpit and painful; 4-5cm lump in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on 13Apr2021 at 12:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), mirtazapine (MANUFACTURER UNKNOWN) and simvastatin (MANUFACTURER UNKNOWN) all taken for unknown indication on unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 23Mar2021 at 12:30 as a single dose. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced 4-5cm lump in left armpit and painful about 12 hours after vaccine injection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of events. The clinical outcome of the event axillary lump and axillary pain was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: The patient broke out in hives about 8 days afterher second vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies (unknown), hypothyroidism and allergies to penicillin. The patient had received an unspecified concomitant medication. The patient had not received any other vaccine within four weeks prior to the COVID vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW6207) via an unspecified route of administration in the right arm on an unknown date in Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021 at 21:00, the patient broke out in hives about 8 days after her second vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event hives which included treatment with cortisone shot and prescriptions. The clinical outcome of the event hives was recovering at the time if this report.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Full body rash. It began at the bottom of her back and then went up her entire back to the sides of her neck. Then over the tops of her shoulders and around her sides onto her breasts and into her underarm area.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 16Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had other medical history (unspecified). The patient had known allergies (unspecified). The patient taken other medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient experienced full body rash. It began at the bottom of her back and then went up entire back to the sides of neck. Then over the tops of her shoulders and around sides onto her breasts and into underarm area. It was then on her abdomen and upper thighs and groin area as well as buttocks and back of her legs. Arms also had rash on inner elbow area. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Betamethasone Dipropionate Cream USP 0.05%. The clinical outcome of the event full body rash. It began at the bottom of her back and then went up entire back to the sides of neck. Then over the tops of her shoulders and around sides onto her breasts and into underarm area. It was then on her abdomen and upper thighs and groin area as well as buttocks and back of her legs. Arms also had rash on inner elbow area was not resolved. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED7534) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 07Apr2021 at 09:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, PTSD (post-traumatic stress disorder), sports induced asthma, chronic back pain (car accident), chronic neck pain (car accident) and allergy to milk chocolate. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) 10 mg for unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had been reporting ailments on the daily tracker. Beginning on 14Apr2021, the patient had a nagging sore throat and exhaustion. On15Apr2021 day of reporting the patient still had these ailments. Enough to be bothersome, but not to head to the doctors. The patient was just wanting to give a heads up. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event nagging sore throat and exhaustion was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Axillary pain, Body temperature, Lymph node pain, Pain
Clinical narrative: Fever 100.5F; Lymph node severe pain under arm; Pain under arm; Upset stomach; Body hurts; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 14Apr2021 at 13:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included ANA (anti-nuclear antibodies) and ankylosing spondylitis. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 12:45, the patient experienced fever 100.5 Fahrenheit (F), lymph node severe, pain under arm, upset stomach, body hurts. On 15Apr2021, the patient underwent body temperature and the result was 100.5 Fahrenheit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of fever 100.5F, lymph node severe, pain under arm, upset stomach, body hurts were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 100.5F; Lymph node severe pain under arm; Pain under arm; Upset stomach; Body hurts; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 14Apr2021 at 13:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included ANA (anti-nuclear antibodies) and ankylosing spondylitis. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021 at 12:45, the patient experienced fever 100.5 Fahrenheit (F), lymph node severe, pain under arm, upset stomach, body hurts. On 15Apr2021, the patient underwent body temperature and the result was 100.5 Fahrenheit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of fever 100.5F, lymph node severe, pain under arm, upset stomach, body hurts were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.